CRANBURY, N.J.--(BUSINESS WIRE)--Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care and specialty pharmacists, is pleased to announce that its CE-accredited activity, “Pharmacists Reaching Out®: Optimizing Patient Management in HR+, HER2– Advanced Breast Cancer, the Role of CDK4/6 Inhibition,” has been awarded overall Best In Class Outcomes of 2019 by the Alliance Industry Summit (AIS). The award submission was selected from more than 30 submissons.
“It is a tremendous honor to be recognized by the Alliance as Overall Best in Class,” said Jim Palatine, RPh, MBA, president of PTCE. “The PTCE team has worked creatively to incorporate patient counseling vignettes into our activities, and we are extremely lucky to have a partner like the National Community Oncology Dispensing Association (NCODA) to support us in capturing higher level outcomes. I am excited to watch our team receive this well-deserved award at this year’s Best In Class presentation at AIS.”
This year, the Best In Class awards presentation will take place during the AIS on Monday, May 6, from 4:45-5:30 p.m. at the Sheraton Inner Harbor Hotel in Baltimore, Maryland.
The activity was supported by an educational grant from Lilly USA, LLC.
For more information, click here.
About Pharmacy Times Continuing Education™
Pharmacy Times Continuing Education™ (PTCE) is a leader in continuing education for retail, health-system, managed care and specialty pharmacists. PTCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE). PTCE’s print, online and live CPE activities are designed to help improve the knowledge, competence and skills of pharmacists so they are better prepared to provide the highest quality of pharmacy care to the patients they serve and to the physicians they assist as part of a multidisciplinary treatment/management team. To learn more about the educational activities sponsored by PTCE, visit our website at https://www.pharmacytimes.org/.
